In response to a warning letter from the FDA that accused the company of making “false or misleading” claims about its bladder cancer drug Anktiva, ImmunityBio says it’s implementing enhanced protocols. More: ImmunityBio responds to FDA scrutiny over Anktiva promotional
read moreA recent episode of ABC’s Scrubs featured an on-screen brand integration with Insulet’s Omnipod device worn by beloved TV doctor Christopher Turk. More: Insulet's Omnipod takes Type 2 diabetes representation to the TV screen in 'Scrubs' revival Source: fierce
read moreNeurocrine Biosciences, forever a possible M&A target in the biopharma industry, is making a major acquisition itself. The purchase adds to a recent string of multibillion-dollar deals. More: Neurocrine, eying ‘blockbuster in the making,’ strikes its largest-ever M&A deal with
read moreWith a new, patient-friendly route of administration, Amgen may have found a way to increase demand for Tepezza. A phase 3 trial of patients with thyroid eye disease has shown that subcutaneous injection of Tepezza by way of an on-body
read moreEli Lilly has published a video about how medicines affect lives to mark its 150th anniversary and the arrival of college basketball stars in its home city. More: Eli Lilly takes the court with 150th anniversary campaign to catch Final
read more© 1994 - 2026 B.M. Pharmaceuticals